Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients. - Wikidata - wikimedia - TriplyDB

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

http://www.wikidata.org/entity/Q37380100

about

Defining ovarian reserve to better understand ovarian aging Prediction of assisted reproductive technique outcome in elevated early follicular phase follicle stimulating hormone with Mullerian inhibiting substance level Reduced neurotrophin receptor tropomyosin-related kinase A expression in human granulosa cells: a novel marker of diminishing ovarian reserve.Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.The role of serum AMH and FF AMH in predicting pregnancy outcome in the fresh cycle of IVF/ICSI: a meta-analysis.Bivariate analysis of basal serum anti-Müllerian hormone measurements and human blastocyst development after IVF.Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol.Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve.Predictive value of hormonal parameters for live birth in women with unexplained infertility and male infertility.Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction Serum and follicular fluid Anti-Mullerian hormone concentrations at the time of follicle puncture and reproductive outcome.Is assessment of anti-Müllerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study.The interrelationship between anti-Müllerian hormone, ovarian follicular populations and age in mares.Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes.Does loop electrosurgical excision procedure of the uterine cervix affect anti-Müllerian hormone levels?Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients.Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.The role of ovarian reserve markers in prediction of clinical pregnancy.The ovarian response to standard gonadotropin stimulation is influenced by AMHRII genotypes.Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study.Nanosized titanium dioxide-induced premature ovarian failure is associated with abnormalities in serum parameters in female mice.

P2860

Q28386414-373E28F3-F825-451E-B901-8D9AD0AA8D7A Q34196639-A3DF0C03-60A0-4683-BB66-F83DC99563A5 Q35126929-B8DE153D-B7A8-4E5C-9DED-15FCAE7BA024 Q35186943-BA370A10-6DA7-49FC-B4F2-500342D2328A Q35479391-0EA61A44-B6C1-4156-AD13-E13440E76D6C Q35620057-2169E84E-8B34-4832-84B9-46C700DD9F84 Q35671932-6FB5BA8B-756C-4C15-8B21-7F704FD77FC8 Q36106435-1C1C2712-27E4-451C-813E-50FF905EB864 Q36529952-825AF7E7-3668-4BA4-B464-497781549DE2 Q36706499-C6CAA720-1206-433D-A380-E96B78E4796E Q37014579-4D70DB94-D0C6-4000-B74B-BA06804D02DE Q37019686-36EEF523-021A-4849-90CB-DCFD45AE4341 Q37613324-45F00F3C-A020-441C-9F72-DDCACA0153D7 Q38306036-1BA56431-EDD7-41F8-A621-0514A44D759D Q38419282-03480D16-57B0-483C-BB45-200DBA6B77DB Q40424332-5AAE8EB1-D6D0-434A-AE0C-F09EEDB12C29 Q42410866-5A43A3EC-B7CE-463E-8DE6-5817FF6D4693 Q44217386-4EEFE211-905C-4EAC-A58C-4BE50206FB4B Q46466248-F6CD4D8F-2E9D-46F9-8DED-185B3B870885 Q47789727-F0FD55B0-1A1B-4BAF-B504-95B3E5E14584 Q48556252-9046DDAB-8B1E-4387-99C4-2A11DF901682 Q51127348-623C262A-397C-482B-8820-95BF90DB08D4 Q55342362-F66F1162-3654-46D8-B28A-625E4933C624

P2860

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

http://www.wikidata.org/entity/Q37380100

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

@en

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

@nl

type

label

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

@en

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

@nl

prefLabel

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

@en

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

@nl

P1433

Q37380100-60D45D0B-DF2D-4497-8576-F6ABA90EE385

P1476

Q37380100-62989A14-A58D-4152-9FEA-1941A6031A78

P2093

Q37380100-22DCCC07-75D8-4FD7-8712-044D170F5688

Q37380100-2C975A63-233A-4BC7-902C-E9F1CCD9E647

Q37380100-39C3FC78-8501-4E75-A4E5-EF6896F70DA9

Q37380100-8107EA2D-588F-4B8D-A76C-BF9A31F70CD1

Q37380100-B8BB1B9A-95BC-45F8-86D9-C15F98324F3D

P2860

Q37380100-0761613B-AAE3-4890-AEEC-7C755C03B3CD

Q37380100-11E1EFA5-6BAB-4ABE-BB55-44C452C91A61

Q37380100-14D11462-665E-4C14-AEBE-DD623A8EDB89

Q37380100-1A7B2D9A-E1FB-4CA9-ADF3-E36A1D959CA6

Q37380100-1D91D64E-7E05-42DE-BB18-07D982E1AE1B

Q37380100-2146DDFE-3896-4615-9CC5-28E1BA9079B1

Q37380100-2188ABB6-6494-4BAC-9B06-999D32E06A45

Q37380100-257DCD01-2014-4C94-81D2-F1607076F180

Q37380100-375B40A1-B85F-4887-8DB3-29B6B5DABA35

Q37380100-3C09B8CF-C1F2-4A2D-A912-37C5E0707A7C

P2888

Q37380100-F0D46E9D-9137-4CD2-8607-828B548ADBD7

P304

Q37380100-62FC3BB4-684C-4C6F-AE82-4892ECE607C1

P31

Q37380100-3C673C76-D7ED-44B4-90E2-F664E20A7C81

P356

Q37380100-62412EF9-BA25-4E00-9CEF-39DF3B45A76E

P433

Q37380100-5908CCB6-5CA6-4470-B87F-711D6FD6DB89

P478

Q37380100-89018027-D50C-407C-95B2-771CEB41FACA

P50

Q37380100-64762C00-BE79-4999-9EB4-8C683A9F2107

P577

Q37380100-E33EEC55-482A-40A4-A880-ED71FA447E42

P5875

Q37380100-FCE6150B-D772-45D8-B95F-53E81049C7BA

P698

Q37380100-07D1BB8C-B09E-414B-947D-FBABBCE76B77

P932

Q37380100-4E995A91-68E5-4EF6-A355-C9F668CE367C

P356

S10815-009-9332-8

P1433

Journal of Assisted Reproduction and Genetics

P1476

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

@en

P2093

Cheng-Hsuan Wu

http://www.w3.org/2001/XMLSchema#string

Horng-Der Tsai

http://www.w3.org/2001/XMLSchema#string

Hsin-Hung Wu

http://www.w3.org/2001/XMLSchema#string

Jyuer-Ger Yang

http://www.w3.org/2001/XMLSchema#string

Yu-Ching Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography.

A systematic review of tests predicting ovarian reserve and IVF outcome.

Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy.

Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception.

Regulation of ovarian function: the role of anti-Müllerian hormone.

Tailoring FSH and LH administration to individual patients.

Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status.

Serum anti-Müllerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles.

Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve.

P2888

s10815-009-9332-8

P304

383-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10815-009-9332-8

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26825954

http://www.w3.org/2001/XMLSchema#string

P698

19768530

http://www.w3.org/2001/XMLSchema#string

P932

2758947

http://www.w3.org/2001/XMLSchema#string